4-1BB-based CAR-T cells armed with autocrine PD-L1 scFv antibody effectively reversed exhaustion and enhanced the anti-tumor immune response in solid tumors and hematologic malignancies by blocking the PD-1/PD-L1 signaling [95]. This evidence concerns the gene CD274 and neoplasm.